Structures of influenza A and B replication complexes give insight into avian to human host adaptation and reveal a role of ANP32 as an electrostatic chaperone for the apo-polymerase.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
19 Aug 2024
Historique:
received: 08 02 2024
accepted: 16 07 2024
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

Replication of influenza viral RNA depends on at least two viral polymerases, a parental replicase and an encapsidase, and cellular factor ANP32. ANP32 comprises an LRR domain and a long C-terminal low complexity acidic region (LCAR). Here we present evidence suggesting that ANP32 is recruited to the replication complex as an electrostatic chaperone that stabilises the encapsidase moiety within apo-polymerase symmetric dimers that are distinct for influenza A and B polymerases. The ANP32 bound encapsidase, then forms the asymmetric replication complex with the replicase, which is embedded in a parental ribonucleoprotein particle (RNP). Cryo-EM structures reveal the architecture of the influenza A and B replication complexes and the likely trajectory of the nascent RNA product into the encapsidase. The cryo-EM map of the FluB replication complex shows extra density attributable to the ANP32 LCAR wrapping around and stabilising the apo-encapsidase conformation. These structures give new insight into the various mutations that adapt avian strain polymerases to use the distinct ANP32 in mammalian cells.

Identifiants

pubmed: 39160148
doi: 10.1038/s41467-024-51007-3
pii: 10.1038/s41467-024-51007-3
doi:

Substances chimiques

Molecular Chaperones 0
ANP32A protein, human 0
RNA-Binding Proteins 0
Nuclear Proteins 0
RNA, Viral 0
ANP32B protein, human 0
RNA-Dependent RNA Polymerase EC 2.7.7.48

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6910

Subventions

Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-18-CE18-0028
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-10-LABX-62-IBEID

Informations de copyright

© 2024. The Author(s).

Références

Wandzik, J. M., Kouba, T. & Cusack, S. Structure and function of influenza polymerase. Cold Spring Harb. Perspect. Med. 11, a038372 (2021).
pubmed: 32341065 pmcid: 8415296 doi: 10.1101/cshperspect.a038372
Zhu, Z., Fodor, E. & Keown, J. R. A structural understanding of influenza virus genome replication. Trends Microbiol. 31, 308–319 (2023).
pubmed: 36336541 doi: 10.1016/j.tim.2022.09.015
Lukarska, M. et al. Structural basis of an essential interaction between influenza polymerase and Pol II CTD. Nature 541, 117–121 (2017).
pubmed: 28002402 doi: 10.1038/nature20594
Krischuns, T., Lukarska, M., Naffakh, N. & Cusack, S. Influenza virus RNA-dependent RNA polymerase and the host transcriptional apparatus. Annu Rev. Biochem 90, 321–348 (2021).
pubmed: 33770447 doi: 10.1146/annurev-biochem-072820-100645
Serna Martin, I. et al. A mechanism for the activation of the influenza virus transcriptase. Mol. Cell 70, 1101–1110.e1104 (2018).
pubmed: 29910112 pmcid: 6024077 doi: 10.1016/j.molcel.2018.05.011
Krischuns, T. et al. Type B and type A influenza polymerases have evolved distinct binding interfaces to recruit the RNA polymerase II CTD. PLoS Pathog. 18, e1010328 (2022).
pubmed: 35605026 pmcid: 9242477 doi: 10.1371/journal.ppat.1010328
Krischuns, T. et al. The host RNA polymerase II C-terminal domain is the anchor for replication of the influenza virus genome. Nat. Commun. 15, 1064 (2024).
pubmed: 38316757 pmcid: 10844641 doi: 10.1038/s41467-024-45205-2
Long, J. S. et al. Species difference in ANP32A underlies influenza A virus polymerase host restriction. Nature 529, 101–104 (2016).
pubmed: 26738596 pmcid: 4710677 doi: 10.1038/nature16474
Sugiyama, K., Kawaguchi, A., Okuwaki, M. & Nagata, K. pp32 and APRIL are host cell-derived regulators of influenza virus RNA synthesis from cRNA. eLife 4, e08939 (2015).
pubmed: 26512887 pmcid: 4718810 doi: 10.7554/eLife.08939
Yu, M., Qu, Y., Zhang, H., & Wang, X. Roles of ANP32 proteins in cell biology and viral replication. Anim. Dis. 2, 22 (2022).
Long, J. S. et al. Species specific differences in use of ANP32 proteins by influenza A virus. eLife 8, e45066 (2019).
pubmed: 31159925 pmcid: 6548507 doi: 10.7554/eLife.45066
Zhang, H. et al. Fundamental contribution and host range determination of ANP32A and ANP32B in influenza A virus polymerase activity. J. Virol. 93, e00174–19 (2019).
pubmed: 30996088 pmcid: 6580979 doi: 10.1128/JVI.00174-19
Park, Y. H. et al. Host-specific restriction of avian influenza virus caused by differential dynamics of ANP32 family members. J. Infect. Dis. 221, 71–80 (2020).
pubmed: 31581291 doi: 10.1093/infdis/jiz506
Zhang, Z. et al. Selective usage of ANP32 proteins by influenza B virus polymerase: implications in determination of host range. PLoS Pathog. 16, e1008989 (2020).
pubmed: 33045004 pmcid: 7580981 doi: 10.1371/journal.ppat.1008989
Sheppard, C. M. et al. An influenza A virus can evolve to use human ANP32E through altering polymerase dimerization. Nat. Commun. 14, 6135 (2023).
pubmed: 37816726 pmcid: 10564888 doi: 10.1038/s41467-023-41308-4
Nilsson-Payant, B. E., tenOever, B. R. & Te Velthuis, A. J. W. The host factor ANP32A is required for influenza A virus vRNA and cRNA synthesis. J. Virol. 96, e0209221 (2022).
pubmed: 34935435 doi: 10.1128/jvi.02092-21
Swann, O. C., Rasmussen, A. B., Peacock, T. P., Sheppard, C. M. & Barclay, W. S. Avian influenza A virus polymerase can utilize human ANP32 proteins to support cRNA but not vRNA synthesis. mBio 14, e0339922 (2023).
pubmed: 36645303 doi: 10.1128/mbio.03399-22
Wang, F. et al. The C-terminal LCAR of host ANP32 proteins interacts with the influenza A virus nucleoprotein to promote the replication of the viral RNA genome. Nucleic acids Res. 50, 5713–5725 (2022).
pubmed: 35639917 pmcid: 9177957 doi: 10.1093/nar/gkac410
Camacho-Zarco, A. R. et al. Multivalent dynamic colocalization of avian influenza polymerase and nucleoprotein by intrinsically disordered ANP32A reveals the molecular basis of human adaptation. J. Am. Chem. Soc. 145, 20985–21001 (2023).
pubmed: 37707433 pmcid: 10540212 doi: 10.1021/jacs.3c06965
Mistry, B. et al Elucidating the interactions between influenza virus polymerase and host factor ANP32A. J. Virol. 94, 10–1128 (2019).
Camacho-Zarco, A. R. et al. Molecular basis of host-adaptation interactions between influenza virus polymerase PB2 subunit and ANP32A. Nat. Commun. 11, 3656 (2020).
pubmed: 32694517 pmcid: 7374565 doi: 10.1038/s41467-020-17407-x
Carrique, L. et al. Host ANP32A mediates the assembly of the influenza virus replicase. Nature 587, 638–643 (2020).
pubmed: 33208942 pmcid: 7116770 doi: 10.1038/s41586-020-2927-z
Peacock, T. P. et al. Mammalian ANP32A and ANP32B proteins drive differential polymerase adaptations in avian influenza virus. J. Virol. 97, e0021323 (2023).
pubmed: 37074204 doi: 10.1128/jvi.00213-23
Huang, L. et al. DAXX represents a new type of protein-folding enabler. Nature 597, 132–137 (2021).
pubmed: 34408321 pmcid: 8485697 doi: 10.1038/s41586-021-03824-5
Chang, S. et al. Cryo-EM structure of influenza virus RNA polymerase complex at 4.3 A resolution. Mol. Cell 57, 925–935 (2015).
pubmed: 25620561 doi: 10.1016/j.molcel.2014.12.031
Fan, H. et al. Structures of influenza A virus RNA polymerase offer insight into viral genome replication. Nature 573, 287–290 (2019).
pubmed: 31485076 pmcid: 6795553 doi: 10.1038/s41586-019-1530-7
Kouba, T. et al. Direct observation of backtracking by influenza A and B polymerases upon consecutive incorporation of the nucleoside analog T1106. Cell Rep. 42, 111901 (2023).
pubmed: 36596301 doi: 10.1016/j.celrep.2022.111901
Worobey, M. Preliminary Report on Genomic Epidemiology of the 2024 H5N1 Influenza A Virus Outbreak in U.S. Cattle. https://virological.org/t/preliminary-report-on-genomic-epidemiology-of-the-2024-h5n1-influenza-a-virus-outbreak-in-u-s-cattle-part-1-of-2/970 (2024).
Nguyen, T.-Q. et al. Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle. bioRxiv, 2024.2005.2001.591751 (2024).
C. D. C. Technical Report: Highly Pathogenic Avian Influenza A(H5N1) Viruses. https://www.cdc.gov/bird-flu/php/technical-report/h5n1-06052024.html (2024).
Foley, E. D. B., Kushwah, M. S., Young, G. & Kukura, P. Mass photometry enables label-free tracking and mass measurement of single proteins on lipid bilayers. Nat. Methods 18, 1247–1252 (2021).
pubmed: 34608319 pmcid: 8490153 doi: 10.1038/s41592-021-01261-w
Chen, K. Y., Santos Afonso, E. D., Enouf, V., Isel, C. & Naffakh, N. Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer. PLoS Pathog. 15, e1008034 (2019).
pubmed: 31581279 pmcid: 6776259 doi: 10.1371/journal.ppat.1008034
Hengrung, N. et al. Crystal structure of the RNA-dependent RNA polymerase from influenza C virus. Nature 527, 114–117 (2015).
pubmed: 26503046 pmcid: 4783868 doi: 10.1038/nature15525
Thierry, E. et al. Influenza polymerase can adopt an alternative configuration involving a radical repacking of PB2 domains. Mol. Cell 61, 125–137 (2016).
pubmed: 26711008 pmcid: 4712189 doi: 10.1016/j.molcel.2015.11.016
Delaforge, E. et al. Large-scale conformational dynamics control H5N1 influenza polymerase PB2 binding to importin alpha. J. Am. Chem. Soc. 137, 15122–15134 (2015).
pubmed: 26424125 doi: 10.1021/jacs.5b07765
Nilsson-Payant, B. E., Sharps, J., Hengrung, N. & Fodor, E. The surface-exposed PA(51-72)-loop of the influenza A Virus polymerase is required for viral genome replication. J. Virol. 92, e00687–18 (2018).
pubmed: 29875249 pmcid: 6069170 doi: 10.1128/JVI.00687-18
Park, Y. H. et al. Asp149 and Asp152 in chicken and human ANP32A play an essential role in the interaction with influenza viral polymerase. FASEB J. 35, e21630 (2021).
pubmed: 33982347 doi: 10.1096/fj.202002006RR
Mehle, A., Dugan, V. G., Taubenberger, J. K. & Doudna, J. A. Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers. J. Virol. 86, 1750–1757 (2012).
pubmed: 22090127 pmcid: 3264373 doi: 10.1128/JVI.06203-11
Peacock, T. P. et al. Swine ANP32A supports avian influenza virus polymerase. J. Virol. 94, e00132–20 (2020).
pubmed: 32269123 pmcid: 7307101 doi: 10.1128/JVI.00132-20
Idoko-Akoh, A. et al. Creating resistance to avian influenza infection through genome editing of the ANP32 gene family. Nat. Commun. 14, 6136 (2023).
pubmed: 37816720 pmcid: 10564915 doi: 10.1038/s41467-023-41476-3
Subbarao, E. K., London, W. & Murphy, B. R. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67, 1761–1764 (1993).
pubmed: 8445709 pmcid: 240216 doi: 10.1128/jvi.67.4.1761-1764.1993
Gabriel, G. et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl Acad. Sci. USA 102, 18590–18595 (2005).
pubmed: 16339318 pmcid: 1317936 doi: 10.1073/pnas.0507415102
Chen, Y. et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381, 1916–1925 (2013).
Mehle, A. & Doudna, J. A. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl Acad. Sci. USA 106, 21312–21316 (2009).
Elderfield, R. A. et al. Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom. J. Virol. 88, 13269–13283 (2014).
pubmed: 25210166 pmcid: 4249111 doi: 10.1128/JVI.01636-14
Manz, B., Brunotte, L., Reuther, P. & Schwemmle, M. Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat. Commun. 3, 802 (2012).
pubmed: 22549831 doi: 10.1038/ncomms1804
Hutchinson, E. C., Orr, O. E., Man Liu, S., Engelhardt, O. G. & Fodor, E. Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5. J. Gen. Virol. 92, 1859–1869 (2011).
pubmed: 21562121 doi: 10.1099/vir.0.032813-0
Kouba, T., Drncova, P. & Cusack, S. Structural snapshots of actively transcribing influenza polymerase. Nat. Struct. Mol. Biol. 26, 460–470 (2019).
pubmed: 31160782 pmcid: 7610713 doi: 10.1038/s41594-019-0232-z
Wandzik, J. M. et al. A structure-based model for the complete transcription cycle of influenza polymerase. Cell 181, 877–893 (2020).
Reich, S. et al. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516, 361–366 (2014).
pubmed: 25409151 doi: 10.1038/nature14009
Huyton, T. & Wolberger, C. The crystal structure of the tumor suppressor protein pp32 (Anp32a): structural insights into Anp32 family of proteins. Protein Sci. 16, 1308–1315 (2007).
pubmed: 17567741 pmcid: 2206682 doi: 10.1110/ps.072803507
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038 doi: 10.1038/nmeth.4193
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153–1160 (2019).
pubmed: 31591578 pmcid: 6858545 doi: 10.1038/s41592-019-0575-8
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
pubmed: 15572765 doi: 10.1107/S0907444904019158
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D Struct. Biol. 74, 531–544 (2018).
pubmed: 29872004 pmcid: 6096492 doi: 10.1107/S2059798318006551
Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084
Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112–128 (2018).
pubmed: 28836357 doi: 10.1002/pro.3280
Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007).
pubmed: 17681537 doi: 10.1016/j.jmb.2007.05.022
Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
pubmed: 28710774 doi: 10.1002/pro.3235
Zheng, L., Baumann, U. & Reymond, J. L. An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res. 32, e115 (2004).
pubmed: 15304544 pmcid: 514394 doi: 10.1093/nar/gnh110
Krischuns, T. et al. Phosphorylation of TRIM28 enhances the expression of IFN-beta and proinflammatory cytokines during HPAIV infection of human lung epithelial cells. Front. Immunol. 9, 2229 (2018).
pubmed: 30323812 pmcid: 6172303 doi: 10.3389/fimmu.2018.02229
Da Costa, B. et al. Temperature-sensitive mutants in the influenza A virus RNA polymerase: alterations in the PA linker reduce nuclear targeting of the PB1-PA dimer and result in viral attenuation. J. Virol. 89, 6376–6390 (2015).
pubmed: 25855727 pmcid: 4474310 doi: 10.1128/JVI.00589-15

Auteurs

Benoît Arragain (B)

European Molecular Biology Laboratory, Grenoble, Cedex 9, France.

Tim Krischuns (T)

Institut Pasteur, Université Paris Cité, CNRS UMR3569, RNA Biology of Influenza Virus, Paris, France.
Heidelberg University, Department of Infectious Diseases, Virology, Schaller Research Group, Heidelberg, Germany.

Martin Pelosse (M)

European Molecular Biology Laboratory, Grenoble, Cedex 9, France.

Petra Drncova (P)

European Molecular Biology Laboratory, Grenoble, Cedex 9, France.

Martin Blackledge (M)

Institut de Biologie Structurale, Université Grenoble-Alpes-CEA-CNRS UMR5075, Grenoble, France.

Nadia Naffakh (N)

Institut Pasteur, Université Paris Cité, CNRS UMR3569, RNA Biology of Influenza Virus, Paris, France.

Stephen Cusack (S)

European Molecular Biology Laboratory, Grenoble, Cedex 9, France. cusack@embl.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH